What's new
Fantasy Football - Footballguys Forums

This is a sample guest message. Register a free account today to become a member! Once signed in, you'll be able to participate on this site by adding your own topics and posts, as well as connect with other members through your own private inbox!

Stock Thread (12 Viewers)

Does anyone know what the protocol is regarding showing trial results?  Could the company release information stating we have studied the results and believe we have hit on all the biomarkers?

Can they basically say "we have not been given approval yet, but our own analysis of the results have shown excellent efficacy".

 
Does anyone know what the protocol is regarding showing trial results?  Could the company release information stating we have studied the results and believe we have hit on all the biomarkers?

Can they basically say "we have not been given approval yet, but our own analysis of the results have shown excellent efficacy".
I'm sure they can say that, but I don't know if it moves the needle much.  After all, other than not having approval or uplisting, the company's shaky reputation is the biggest thing keeping people on the sideline that I can see.  Its also the biggest thing the shorts had going for them in the bear attack.  

They are going to need independent verification from someone with nothing to gain (personally) in order for this thing to move, IMO.

Just a newbie perspective.  I'm looking to add, but I have had terrible luck with my timing so far.

 
Does anyone know what the protocol is regarding showing trial results?  Could the company release information stating we have studied the results and believe we have hit on all the biomarkers?

Can they basically say "we have not been given approval yet, but our own analysis of the results have shown excellent efficacy".
My understanding, which could be wrong, is the information can be made public at that time and would be available for everyone to give their .10 on.

Again - it’s all about the results.  If they are good to great and they can talk about the results openly without fear of SEC violations this will willingly get picked up by anyone and everyone.

I can virtually guarantee if it’s a slam dunk great results Trump will speak on it.  They are desperate to open up again.

All of this is a giant “If”.

 
What is going to happen to the stock price if the M2M trial results are marginally good but not great?
Assume it’s sent back for more testing then? I dunno, have thought this too. I figured it would trade down but then come back up on any positivity a few weeks later. 

 
My understanding, which could be wrong, is the information can be made public at that time and would be available for everyone to give their .10 on.

Again - it’s all about the results.  If they are good to great and they can talk about the results openly without fear of SEC violations this will willingly get picked up by anyone and everyone.

I can virtually guarantee if it’s a slam dunk great results Trump will speak on it.  They are desperate to open up again.

All of this is a giant “If”.
Trump talking about this after we’ve spent months discussing it will be incredibly surreal. 

 
If the news is great, those that sell at $10 will have their shares easily grabbed up.  
If the headline is “holy Sh!t we cured COVID” it won’t open up under $15. And thats “only” a ~$11B valuation.

 
Last edited by a moderator:
If the headline is “whole Sh!t we cured COVID” it won’t open up under $15. And thats “only” a ~$11B valuation.
If that happens you’ll see such a shortage of shares I wouldn’t be surprised a $500 sell order gets triggered. Also be sitting at your computer that day because when it turns south it will fall faster than a short attack. Guys like Chet will be locking in their millions 

 
If that happens you’ll see such a shortage of shares I wouldn’t be surprised a $500 sell order gets triggered. Also be sitting at your computer that day because when it turns south it will fall faster than a short attack. Guys like Chet will be locking in their millions 
Assuming the announcement comes pre-market I’m taking that day off. Wouldn’t be able to focus on work either way. 

 
So are we supposed to believe in this Bean interview tonight that Nader hasn’t seen any results yet?

I though I read earlier in the week that once the data is unblinded the top line results are quick to analyze...which makes a ton of sense.

 
So are we supposed to believe in this Bean interview tonight that Nader hasn’t seen any results yet?

I though I read earlier in the week that once the data is unblinded the top line results are quick to analyze...which makes a ton of sense.
We will need some body- and voice-language experts to give their reads on tonight's interview. 

 
So are we supposed to believe in this Bean interview tonight that Nader hasn’t seen any results yet?

I though I read earlier in the week that once the data is unblinded the top line results are quick to analyze...which makes a ton of sense.
I would say he almost has to know right? I won’t be watching but am very interested in reading what he had to say. Somebody will have a write-up. 

 
Is Nader's interview with Drbeen live or prerecorded?  And why is Nader giving an interview about methodology when he isn't a scientist?

 
The problem is IF we get good news on this trial it will be before they are even listed on Nasdaq (IF they are approved) and are therefore out of reach for RHers

Given ongoing paperwork issues, I don't think uplisting Is a slam dunk. 
Right, the timing sucks.  That's why I wish they had pushed harder to get uplisted prior to these trial results.  Will this thing ever go to $30 as an OTC stock?  I dunno, I'm not super confident about that.  It would literally have to be the bang-up #1 treatment for curing COVID to do that most likely.

But if it were on the Naz right now in this market, I would say there were a decent chance it would go to $30 this week.  $5 to $30 is not a huge move in this market with even mildly positive COVID news.  It's been happening almost every day, again, on news less optimistic than what Cydy has had so far.

20x in a day? Seems ambitious.
20x is probably excessive but in this insane market there is a new stock going 10x-20x almost every few days.  UONE went from $2 to $36 in a day because they have a black CEO and people were empathetic to the BLM movement.  This isn't a normal market.  Can you imagine the move if an uplisted company announced that they had the cure for COVID and it was skipping phase 3 to go straight into production?  Every Robinhooder on the planet would be FOMO'ing into the "buy at market price" button at the same time. 

Right now small biotechs are going up 5x-10x just on a whiff of a rumor that some news might be dropping soon.

What is going to happen to the stock price if the M2M trial results are marginally good but not great?
This is where not being listed hurts.  Marginally good results in the hands of RH = rocket.  Marginally good results as an OTC, I have no idea.

 
Last edited by a moderator:
We will need some body- and voice-language experts to give their reads on tonight's interview. 
Yep, Bean will ask if Nader has seen the results, Nader will say no or something along those lines and there will be a few thousand posts across cydy forums analyzing how one of his facial twiches was a signal to longs.

With that said, I will be watching for his signal to me 🧐

 
Last edited by a moderator:
20x is probably excessive but in this insane market there is a new stock going 10x-20x almost every few days.  UONE went from $2 to $36 in a day because they have a black CEO and people were empathetic to the BLM movement.  This isn't a normal market.  Can you imagine the move if an uplisted company announced that they had the cure for COVID and it was skipping phase 3 to go straight into production?  Every Robinhooder on the planet would be FOMO'ing into the "buy at market price" button at the same time. 

Right now small biotechs are going up 5x-10x just on a whiff of a rumor that some news might be dropping soon.
True, but even after that pump UONE was still only at a 300 million dollar market cap.

FAR easier to pump a super low cap company.  

A CYDY 10x's pump from 2.5 billion to 25 billion cap is completely different.

Someone else posted they wouldn't be surprised to see it hit $500 on a pump (260 billion market cap).   I'm all for optimism, but peoples hopes and dreams are getting out of line with reality.  

 
True, but even after that pump UONE was still only at a 300 million dollar market cap.

FAR easier to pump a super low cap company.  

A CYDY 10x's pump from 2.5 billion to 25 billion cap is completely different.

Someone else posted they wouldn't be surprised to see it hit $500 on a pump (260 billion market cap).   I'm all for optimism, but peoples hopes and dreams are getting out of line with reality.  
$500 :lmao:  come on. People are nuts. 

 
So are we supposed to believe in this Bean interview tonight that Nader hasn’t seen any results yet?

I though I read earlier in the week that once the data is unblinded the top line results are quick to analyze...which makes a ton of sense.
imo they have seen the unblinded results. If a bunch of people got better, its pretty safe to assume it was from leronlab, but technically unsure until the unblinding. That's what NP's demeanor was telling me Friday

 
True, but even after that pump UONE was still only at a 300 million dollar market cap.

FAR easier to pump a super low cap company.  

A CYDY 10x's pump from 2.5 billion to 25 billion cap is completely different.

Someone else posted they wouldn't be surprised to see it hit $500 on a pump (260 billion market cap).   I'm all for optimism, but peoples hopes and dreams are getting out of line with reality.  
Might as wish for a 750 share price which would allow us to purchase JNJ to handle manufacture and distribution.

 
A few points for rational conversation.

Every $3 in CYDY stock price = $2.1B in Market Cap.

Bristol Myers, Merck, J&J, Pfizer And the like are 150B-230B companies.

In the past 6 months market darling Monderna went from $7B to $35B.  The stock had run from $7B to to ~$15B Mkt Cap on speculation they may “have a cure” and when news came out and trump mentioned the Market Cap spiked about $20B, but some was baked in.  
 

@chet opined he thinks a small cap Bio company typically trades at 10X Future projected revenue.  If things went well based on some projections and back of the napkin We we collectively looked before I thought we landed at ~20-25B
 

My Take: we aren’t going to sniff higher than 25B until such time we are all the way though FDA approval or get a buy out.  Over the moon results Combined with support from media and other people in the medical community with an eye towards a fast track approval get us to 13-15B.
 

that would take us from $5.50 a share to $18

now that being said between short covering and executive branch support and general mania around “the cure for COVID” it’s not imposable that this could get out of hand to the upside.  That said anyone saying $50+ a share out of the box Is probably asking a bit much....... but I’d love to be wrong.

 
True, but even after that pump UONE was still only at a 300 million dollar market cap.

FAR easier to pump a super low cap company.  

A CYDY 10x's pump from 2.5 billion to 25 billion cap is completely different.

Someone else posted they wouldn't be surprised to see it hit $500 on a pump (260 billion market cap).   I'm all for optimism, but peoples hopes and dreams are getting out of line with reality.  
That’s not exactly what I posted. What I said was that if the news is this cures covid there will be such a rush to buy this stock that you could see some market orders get filled at stupid high prices if shares become scarce

 
Yep, Bean will ask if Nader has seen the results, Nader will say no or something along those lines and there will be a few thousand posts across cydy forums analyzing how one of his facial twiches was a signal to longs.

With that said, I will be watching for his signal to me 🧐
If someone disagrees please let me know.  
 

I think there is a roughly 0.0000001% chance NP isn’t aware of the results at this point.  Maybe not every last little detail committed to memory but he damn well knows what the headline of the eventual press release is going to read.

He never said that they unblinded before he filmed on Friday just that they would.  Everyone, including myself, seemed to pick up a very positive vibe from him Friday.  

It’s not impossible we don’t find out tonight but that would mean they are announcing Via PR at 6AM Monday.  I think it’s unlikely but you never know.

if he doesn’t spill the beans demeanor and other “tells” should help clue us in.  If he is glowing similar to Friday it’s not going to dampen my spirits.  If all of a sudden it looks like someone kicked his dog that would make me nervous.

another item that has been pointed out - the posted a few Sr level accounting jobs over the weekend.  That may have more to do with uplisting conditions but you don’t add to overhead costs unless you have too and it’s supported by revenues.

 
A few points for rational conversation.

Every $3 in CYDY stock price = $2.1B in Market Cap.

Bristol Myers, Merck, J&J, Pfizer And the like are 150B-230B companies.

In the past 6 months market darling Monderna went from $7B to $35B.  The stock had run from $7B to to ~$15B Mkt Cap on speculation they may “have a cure” and when news came out and trump mentioned the Market Cap spiked about $20B, but some was baked in.  
 

@chet opined he thinks a small cap Bio company typically trades at 10X Future projected revenue.  If things went well based on some projections and back of the napkin We we collectively looked before I thought we landed at ~20-25B
 

My Take: we aren’t going to sniff higher than 25B until such time we are all the way though FDA approval or get a buy out.  Over the moon results Combined with support from media and other people in the medical community with an eye towards a fast track approval get us to 13-15B.
 

that would take us from $5.50 a share to $18

now that being said between short covering and executive branch support and general mania around “the cure for COVID” it’s not imposable that this could get out of hand to the upside.  That said anyone saying $50+ a share out of the box Is probably asking a bit much....... but I’d love to be wrong.
All good points.  It's fair to note that this isn't a normal market, though.  People right now, especially Robinhooders, aren't sitting around reading market caps and deciding if it makes sense within the bounds of a company's projected revenue.

Everyone told us TSLA's market cap was stupid overvalued $150 billion ago.  Nikola went to $30 billion with little more than CGI drawings of a product that didn't exist and was years away from making an impact.  Like you mentioned Moderna is already at $35 billion and they're still 3 months behind CYDY in trials with a lot iffier data.

In a pie in the sky scenario, if something (whether LL or something else) skips phase 3 trials and is fast tracked into production because it basically cures this disease then $35 billion market cap is not a barrier that is going to bother anyone on the run-up.  It just doesn't matter on those kind of momentum stocks in this market.  At least the ones that are listed.

 
Last edited by a moderator:
another item that has been pointed out - the posted a few Sr level accounting jobs over the weekend.  That may have more to do with uplisting conditions but you don’t add to overhead costs unless you have too and it’s supported by revenues.
You guys have been crapping on NP, but he’s playing 5d chess and this has been the ultimate pump and dump. They are covering every angle

 
All good points.  It's fair to note that this isn't a normal market, though.  People right now, especially Robinhooders, aren't sitting around reading market caps and deciding if it makes sense within the bounds of a company's projected revenue.

Everyone told us TSLA's market cap was stupid overvalued $150 billion ago.  Nikola went to $30 billion with little more than CGI drawings of a product that didn't exist and was years away from making an impact.  Like you mentioned Moderna is already at $35 billion and they're still 3 months behind CYDY in trials with a lot iffier data.

In a pie in the sky scenario, if something (whether LL or something else) skips phase 3 trials and is fast tracked into production because it basically cures this disease then $35 billion market cap is not a barrier that is going to bother anyone on the run-up.  It just doesn't matter on those kind of momentum stocks in this market.  At least the ones that are listed.
Yes. This is the ultimate can’t apply old principles to current situation scenario. 

 
Yes. This is the ultimate can’t apply old principles to current situation scenario. 
Look that’s 100% fair.  “The Cure” to what has had the entire world in fear for the last 4 months could explode to 150B Market Cap.  Maybe “we” are the new Merck.

im just trying to paint what a reasonable picture would look like instead of “LOLZ YOLO $250 a SHARE, Stonks go up Bizzos” and not having a bit of a plan.

 
Yes. This is the ultimate can’t apply old principles to current situation scenario. 
Agree and could apply to uplisting to NASDAQ as well.  Would imagine they would not mind having the increased positive exposure IF results come out great...maybe fast tracked up list?

 
You guys have been crapping on NP, but he’s playing 5d chess and this has been the ultimate pump and dump. They are covering every angle
If this ends up going up in flames he will be the most hated human being in FBG history.  
 

the jobs, the international talks, the pressers, the agreements for distribution, the uplisting..... it would make AF look like a genius.

 
You guys have been crapping on NP, but he’s playing 5d chess and this has been the ultimate pump and dump. They are covering every angle
He may even go so far as to have a successful product just to pump up the price even higher and then dump it off at a high price to a big company, making millions in the process.  Such chicanery!

 
Look that’s 100% fair.  “The Cure” to what has had the entire world in fear for the last 4 months could explode to 150B Market Cap.  Maybe “we” are the new Merck.

im just trying to paint what a reasonable picture would look like instead of “LOLZ YOLO $250 a SHARE, Stonks go up Bizzos” and not having a bit of a plan.
I agree. I don’t think anybody here is saying that. Most seem to expect 20-30 a share. I’d be out of my mind thrilled with 20. 

 
Last edited by a moderator:
If this ends up going up in flames he will be the most hated human being in FBG history.  
 

the jobs, the international talks, the pressers, the agreements for distribution, the uplisting..... it would make AF look like a genius.
Naw.  He has 20+ other indications to pump if things go poorly.  NP will never die.  People don't abandon their Gods.  

 
How many shares do you own?
zero point zero.  I find the situation fascinating. 

I 100% hope this drug that's been around 20+ years is the answer to at least one disease they are trying it on.  The history of it and the CEO makes me think they will fail though.   Just being honest.  I'm wrong 58% of the time.

 
Monday can't come soon enough
day after tomorrow. 

I'm going to get a new puppy tomorrow and I suppose that will help me while away 10-12 hours.

I went to the convenience store to grab a six pack and saw a homeless guy sitting in the 100 degree sun with a bottle of Fireball between his legs. I walked over and gave him a 50 and told him to get something cold to drink and walked away. I'm feeling awfully good and already paying some of it forward.

 

Users who are viewing this thread

Back
Top